Log In
BCIQ
Print this Print this
 

NK-814

  Manage Alerts
Collapse Summary General Information
Company NeRRe Therapeutics Ltd.
DescriptionNeurokinin 1 (NK1) substance P receptor (TACR1) and TACR3 (NK3R) antagonist
Molecular Target Neurokinin 1 (NK1) substance P receptor (TACR1) ; Neurokinin 3 (NK3) receptor (TACR3) (NK3R)
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today